Liabilities / Assets
42nd percentile
Higher debt load relative to assets than 42% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
42nd percentile
Higher debt load relative to assets than 42% of similar nonprofits.
Liabilities / Revenue
49th percentile
Higher debt load relative to revenue than 49% of similar nonprofits.
Net Margin
7th percentile
Higher net margin than 7% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
14th percentile
Faster asset growth than 14% of similar nonprofits.
Revenue Growth
70th percentile
Faster revenue growth than 70% of similar nonprofits.
Assets
Down$872,303
Down $165,707 (-16%) from 2021
Net Assets
Down$866,538
Down $167,355 (-16%) from 2021
Liabilities
Up$5,765
Up $1,648 (+40%) from 2021
Revenue
Up$294,776
Up $68,101 (+30%) from 2021
Expenses
Down$461,492
Down $53,895 (-10%) from 2021
Net Income
Up-$166,716
Up $121,996 (+42%) from 2021
This 2022 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Reboot Rx is a nonprofit that expands access to affordable cancer treatments by repurposing generic drugs.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2022 • Form 990Summary only. Only limited summary data is available for this year.